ACAD
41.57
-0.12
-0.29%
AEMD
6.75
-0.15
-2.17%
APRI
1.87
+0.02
+1.08%
ARNA
4.52
+0.08
+1.80%
ATEC
1.36
-0.03
-2.16%
CNAT
5.02
-0.14
-2.71%
CRXM
0.305
-0.022
-6.614%
CYTX
0.53
-0.018
-3.2505%
DXCM
79.71
+0.35
+0.44%
GNMK
8.97
+0.06
+0.67%
HALO
22.78
+0.68
+3.08%
ILMN
220.51
+0.44
+0.20%
INNV
0.12
0.00
0.00%
INO
7.87
-0.05
-0.63%
ISCO
0.048
+0.005
+10.4651%
ISIS
55.43
-0.7
-1.25%
LGND
98.93
+0.33
+0.33%
LPTN
0.256
-0.019
-6.9793%
MBVX
2.651
-0.059
-2.177%
MEIP
1.74
-0.03
-1.69%
MNOV
3.94
-0.08
-1.99%
MRTX
31.85
+0.55
+1.76%
MSTX
0.462
-0.018
-3.7708%
NBIX
48.32
+1.01
+2.13%
NUVA
47.49
+0.2
+0.42%
ONCS
6.12
-0.23
-3.62%
ONVO
3.73
-0.01
-0.27%
OREX
4.77
+0.01
+0.21%
OTIC
22.06
-0.03
-0.14%
QDEL
22.8
-0.21
-0.91%
RCPT
198.25
+3.34
+1.71%
RGLS
10.32
+0.12
+1.18%
RMD
55.38
+0.07
+0.13%
SCIE
0.015
-0.002
-9.3750%
SPHS
0.8
-0.02
-2.79%
SRNE
17.29
+0.61
+3.66%
TROV
10.1
+0.57
+5.98%
VICL
0.7
0.00
+0.01%
ZGNX
13.03
+0.23
+1.80%
ACAD
41.57
-0.12
-0.29%
AEMD
6.75
-0.15
-2.17%
APRI
1.87
+0.02
+1.08%
ARNA
4.52
+0.08
+1.80%
ATEC
1.36
-0.03
-2.16%
CNAT
5.02
-0.14
-2.71%
CRXM
0.305
-0.022
-6.614%
CYTX
0.53
-0.018
-3.2505%
DXCM
79.71
+0.35
+0.44%
GNMK
8.97
+0.06
+0.67%
HALO
22.78
+0.68
+3.08%
ILMN
220.51
+0.44
+0.20%
INNV
0.12
0.00
0.00%
INO
7.87
-0.05
-0.63%
ISCO
0.048
+0.005
+10.4651%
ISIS
55.43
-0.7
-1.25%
LGND
98.93
+0.33
+0.33%
LPTN
0.256
-0.019
-6.9793%
MBVX
2.651
-0.059
-2.177%
MEIP
1.74
-0.03
-1.69%
MNOV
3.94
-0.08
-1.99%
MRTX
31.85
+0.55
+1.76%
MSTX
0.462
-0.018
-3.7708%
NBIX
48.32
+1.01
+2.13%
NUVA
47.49
+0.2
+0.42%
ONCS
6.12
-0.23
-3.62%
ONVO
3.73
-0.01
-0.27%
OREX
4.77
+0.01
+0.21%
OTIC
22.06
-0.03
-0.14%
QDEL
22.8
-0.21
-0.91%
RCPT
198.25
+3.34
+1.71%
RGLS
10.32
+0.12
+1.18%
RMD
55.38
+0.07
+0.13%
SCIE
0.015
-0.002
-9.3750%
SPHS
0.8
-0.02
-2.79%
SRNE
17.29
+0.61
+3.66%
TROV
10.1
+0.57
+5.98%
VICL
0.7
0.00
+0.01%
ZGNX
13.03
+0.23
+1.80%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …